According to a market report by Lucintel, the future of the global thyroid gland disorder treatment market looks promising with opportunities in the hypothyroidism and hyperthyroidism markets. The global thyroid gland disorder treatment market is expected to reach an estimated $3.06 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are rising prevalence of thyroid disorders, growing demand for personalized medicine, and increasing number of disease awareness programs in the developing countries.

A more than 150 – page report is developed to understand Trends, opportunity and forecast in thyroid gland disorder treatment market to 2030 by route of administration (oral, intravenous route, and others), drug type (levothyroxine, liothyronine, propylthiouracil, imidazole-based compounds, and others), disease type (hypothyroidism and hyperthyroidism), and region (North America, Europe, Asia Pacific, and the Rest of the World).

In this market, oral and intravenous route are the major segments of thyroid gland disorder treatment market by route of administration. Lucintel forecasts that oral will remain the larger segment over the forecast period due to the fact that the medicines available on the market are tablets or pills, which can be easily administered every day by a patient.

Within this market, hypothyroidism will remain the larger segment due to rising incidence of iodine deficiency worldwide.

Download sample by clicking on thyroid gland disorder treatment market

North America will remain the largest region over the forecast period due to growing prevalence of thyroid diseases, new product launches and approvals, and strong concentration of market players.

Abbvie, Pfizer, Merck, Lannett Company, Allergan, Mylan, GlaxosmithKline, Novartis, RLC LABS, and Abbott Laboratories are the major suppliers in the thyroid gland disorder treatment market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056

Explore Our Latest Publications

Insurance Protection Products Market in Canada

Morphine Market in Canada

Emi Shielding Market in Canada

Sheet Metal Fabrication Service Market in Canada

Data Center Robotic Market in Canada

Data Center Transformer Market in Canada